Health Bureau Approves HK$207 Million for 204 Medical Research Projects
RTHK · 2 SOURCES1 day ago2 MIN
Summary
The Health Bureau's Research Council convened its 30th meeting on Tuesday, chaired by Health Secretary Lo Chung-mau, to review the translation outcomes of research funded by the Medical and Health Research Fund and discuss strategies to enhance project impact. The meeting approved a total funding commitment of HK$207 million to support 204 research projects, with applications received between December last year and March this year. Among funded projects, 123 have demonstrated successful research translation, with nearly 80% publishing their findings in peer-reviewed journals and over 40% securing additional funding for follow-up studies. The Health Bureau emphasized that these efforts align with the upcoming Hong Kong Five-Year Plan and Policy Address, positioning the city as an international medical innovation hub.
Key Points
- The Research Council approved HK$207 million in funding commitments for 204 research projects during its 30th meeting
- Applications reviewed were received between December 2025 and March 2026 from the Medical and Health Research Fund
- 123 funded projects successfully translated their research, with nearly 80% publishing in peer-reviewed journals
- Over 40% of translated projects secured additional funding from the fund and other sources for follow-up research
- 26 projects reported patent applications for commercialization, covering therapeutic and diagnostic innovations
- Research applications include cancer prevention, clinical trials, digital healthcare, and biomarkers for diseases like acute myeloid leukemia
Why It Matters
The successful translation of medical research into clinical applications directly benefits Hong Kong patients by bringing innovative treatments and diagnostic tools into public healthcare services. These initiatives support the government's broader ambition to establish Hong Kong as an international medical innovation hub, aligning local research with national development requirements while fostering economic opportunities through research commercialization and patent development .
The successful translation of medical research into clinical applications directly benefits Hong Kong patients by bringing innovative treatments and diagnostic tools into public healthcare services. These initiatives support the government's broader ambition to establish Hong Kong as an international medical innovation hub, aligning local research with national development requirements while fostering economic opportunities through research commercialization and patent development .